2011-13539. National Cancer Institute; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis Panel; SBIR Phase IIB Bridge Awards.

    Date: June 29-30, 2011.

    Time: 8 a.m. to 5 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Hilton Hotel—Washington DC North DC/Gaithersburg, 620 Perry Parkway, Gaithersburg, MD 20877.

    Contact Person: Savvas C Makrides, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 8053, Bethesda, MD 20892, 301-496-7421, makridessc@mail.nih.gov,

    Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Anticancer Agents.

    Date: June 29, 2011.

    Time: 1 to 5 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: National Institutes of Health, 6116 Executive Boulevard, Room 706, Rockville, MD 20852 (Telephone Conference Call).

    Contact Person: Timothy C. Meeker, M.D., PhD, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8103, Bethesda, MD 20892, (301) 594-1279, meekert@mail.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

    Start Signature

    Dated: May 25, 2011.

    Jennifer S. Spaeth,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2011-13539 Filed 5-31-11; 8:45 am]

    BILLING CODE 4140-01-P